Sign in Subscribe
Adipose tissue

Left Ventricular Diastolic Dysfunction: A Target for Therapeutic Intervention

Strategic Insights

— 1 min read

Researchers at Huazhong University of Science and Technology have conducted a study on left ventricular diastolic dysfunction (LVDD), a condition associated with diminished quality of life and high mortality. According to the study, LVDD can progress to heart failure, and timely diagnosis and effective treatment rely on a thorough understanding of the pathogenesis involved. The study highlights the potential role of epicardial adipose tissue (EAT) in LVDD and suggests that interventions aimed at reducing EAT may improve diastolic function. The researchers also note that some interventions, such as medications, lifestyle modifications, and bariatric surgery, have shown promise in decreasing EAT and improving diastolic parameters.

Key Takeaways:

  • Left ventricular diastolic dysfunction (LVDD) can progress to heart failure, leading to diminished quality of life and high mortality.
  • Epicardial adipose tissue (EAT) is a potential target for therapeutic intervention in LVDD.
  • Increased EAT has been linked to LVDD in various clinical settings, including hypertension, coronary artery disease, diabetes, and obesity.
  • Therapeutic strategies aimed at reducing EAT, such as medications, lifestyle modifications, and bariatric surgery, may improve diastolic function.
  • Echocardiography and cardiac magnetic resonance are the primary imaging modalities for evaluating left ventricular diastolic function.
  • Recent advancements in the clinical evaluation of LVDD have elucidated the pathophysiological and therapeutic roles of EAT in LVDD.
  • Chun-Qiong Ran and his team at Huazhong University of Science and Technology have conducted research in this area, highlighting the potential benefits of EAT reduction in LVDD.

Statistics:

  • LVDD is a condition associated with high mortality (news editors obtained a quote from the research).
  • EAT is a potential target for therapeutical intervention in LVDD, with some interventions showing promise in reducing EAT and improving diastolic parameters.
  • Bariatric surgery, medications, and lifestyle modifications have been linked to improvements in diastolic parameters.
  • The study has compiled recent advancements in the clinical evaluation of LVDD, highlighting the pathophysiological and therapeutic roles of EAT in LVDD.
  • The research concluded that a comprehensive understanding of the pathogenesis involved in LVDD is essential for timely diagnosis and effective treatment.

Sources:

  • Epicardial Adipose Tissue: A Potential Target to Improve Left Ventricular Diastolic Dysfunction (Reviews in Cardiovascular Medicine, 2025,26(9):39224)
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (Division of Endocrinology, Department of Internal Medicine)
  • Chun-Qiong Ran (lead author, Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
  • IMR Press (publisher of Reviews in Cardiovascular Medicine)

Read more